Skip to content
Axcess News – Lifestyle
Author:
Aktis Oncology Inc.
Aktis Oncology Receives U.S. FDA Fast Track Designation for AKY-1189, a Nectin-4 Miniprotein Radioconjugate
March 5, 2026
←
Previous Page
1
2